Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 52Insulin Resistance 12Metabolic Syndrome 4Hyperandrogenism 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Obesity 3Breast Neoplasms 3Weight Loss 2Rare Diseases 2Infertility, Female 2Hyperinsulinism 2Endocrine System Diseases 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Premature Birth 1Obesity, Morbid 1Metformin 1Menstruation Disturbances 1Inflammation 1Infertility 1Hyperglycemia 1Head and Neck Neoplasms 1Glucose Intolerance 1Endometrial Neoplasms 1Diabetes Mellitus 1Depression 1

Interventions

Self Care 1Metformin 1Kangaroo-Mother Care Method 1Inositol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Premature Birth × Metformin × Clear all
NCT01587378 2019-02-26

PregMet2

Norwegian University of Science and Technology

Phase NA Completed
489 enrolled

Abortion, Spontaneous, Polycystic Ovary Syndrome, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡